2018
DOI: 10.1016/j.pnpbp.2018.02.010
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological analysis of zebrafish lphn3.1 morphant larvae suggests that saturated dopaminergic signaling could underlie the ADHD-like locomotor hyperactivity

Abstract: Polymorphisms in the gene coding for the adhesion G-protein coupled receptor LPHN3 are a risk factor for attention-deficit/hyperactivity disorder (ADHD). Transient down-regulation of latrophilin3.1 (lphn3.1), the zebrafish LPHN3 homologue, causes hyperactivity. Zebrafish injected with a lphn3.1-specific morpholino are hyperactive and display an impairment in dopaminergic neuron development. In the present study we used lphn3.1 morphants to further characterize the changes to dopaminergic signaling that trigger… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
32
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 38 publications
(35 citation statements)
references
References 50 publications
(82 reference statements)
3
32
0
Order By: Relevance
“…The aGPCR latrophilin 3 (ADGRL3, human homolog) was recently associated with an increased risk of attention-deficit/hyperactivity disorder (ADHD) and substance use in human genetic studies 3 , 4 . Gene knockdown of ADGRL3 homologs in flies 5 , fish 6 , 7 , rat 8 and mouse 9 has been associated with a pan-species hyperlocomotor phenotype, as well as dysregulation of dopamine signaling. Thus, ADGRL3 may offer a novel target for modulating dopamine signaling, with important therapeutic implications for the treatment of ADHD and other neuropsychiatric disorders that involve dopamine dysfunction, such as schizophrenia.…”
Section: Introductionmentioning
confidence: 99%
“…The aGPCR latrophilin 3 (ADGRL3, human homolog) was recently associated with an increased risk of attention-deficit/hyperactivity disorder (ADHD) and substance use in human genetic studies 3 , 4 . Gene knockdown of ADGRL3 homologs in flies 5 , fish 6 , 7 , rat 8 and mouse 9 has been associated with a pan-species hyperlocomotor phenotype, as well as dysregulation of dopamine signaling. Thus, ADGRL3 may offer a novel target for modulating dopamine signaling, with important therapeutic implications for the treatment of ADHD and other neuropsychiatric disorders that involve dopamine dysfunction, such as schizophrenia.…”
Section: Introductionmentioning
confidence: 99%
“…There was no statistically significant interaction between treatment and time ( F 25,1245 = 1.39, P = 0.096). Because of this reduction in locomotor activity over time, supported by other reports, 69‐71 we repeated the analysis on the first 30 minutes only. The repeated‐measure ANOVA showed a significant main effect of the treatment ( F 5,249 = 2.565, P = 0.028).…”
Section: Resultsmentioning
confidence: 74%
“…For example, in other zebrafish models of chemical-induced hyperactivity, exposed animals also showed impaired learning and memory (Chen et al 2012;Saili et al 2012;Knecht et al 2017). Hyperactivity has also been observed in various zebrafish models of intellectual disability (Kim et al 2014;Chen et al 2018;Lange et al 2018). Therefore, it may be that the hyperactivity observed in zebrafish exposed to Ag-NPs is in fact an impaired acclimation to the dark 2 period.…”
Section: Discussionmentioning
confidence: 99%